Literature DB >> 33327594

HLA-DRB1*07:01 and *08:02 Alleles Confer a Protective Effect Against ACPA-Positive Rheumatoid Arthritis in a Latin American Admixed Population.

Patricia Castro-Santos1,2, Jordi Olloquequi1, Ricardo A Verdugo3,4, Miguel A Gutiérrez5,6, Carmen Pinochet7, Luis A Quiñones8,9, Roberto Díaz-Peña1.   

Abstract

HLA-DRB1 shared epitope (SE) alleles are important genetic contributors for the risk of developing anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis (RA), particularly in Caucasians. We aimed to analyze the contribution of HLA-DRB1 alleles and single nucleotide polymorphisms (SNPs) within the major histocompatibility complex (MHC) region to the susceptibility to develop ACPA-positive RA in a Latin American (LA) population with admixed ancestry. A total of 289 ACPA-positive RA patients and 510 controls were enrolled in this study. The presence of HLA-DRB1*04:01, *09:01 and *10:01 was increased in ACPA-positive RA patients compared with healthy controls (p < 0.0001, p < 0.001 and p < 0.01, respectively), whereas DRB1*07:01 and *08:02 was associated with a decreased risk of ACPA-positive RA (p < 0.001 and p < 0.01, respectively). These results showed a strong correlation with estimates from studies in Asians but not in Caucasian populations. The present study describes the protective effects of the HLA-DRB1*07:01 and *08:02 alleles in ACPA-positive RA patients in a LA population for the first time. Identifying relationships between HLA-DRB1 alleles and RA is important for identifying disease associations in different ethnic groups in order to reach a better understanding of RA worldwide.

Entities:  

Keywords:  ACPA; HLA; HLA-DRB1; Latin American; admixed population; rheumatoid arthritis

Year:  2020        PMID: 33327594     DOI: 10.3390/biology9120467

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  3 in total

1.  Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated With Hemagglutination Inhibition Antibody Response to Influenza Vaccine.

Authors:  Shuyi Zhong; Hejiang Wei; Mao Li; Yanhui Cheng; Simin Wen; Dayan Wang; Yuelong Shu
Journal:  Front Genet       Date:  2022-02-07       Impact factor: 4.599

2.  HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine.

Authors:  Juan Francisco Gutiérrez-Bautista; Antonio Sampedro; Esther Gómez-Vicente; Javier Rodríguez-Granger; Juan Antonio Reguera; Fernando Cobo; Francisco Ruiz-Cabello; Miguel Ángel López-Nevot
Journal:  Vaccines (Basel)       Date:  2022-03-06

3.  Epitope Mapping of Pathogenic Autoantigens on Sjögren's Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques.

Authors:  Shivai Gupta; Danmeng Li; David A Ostrov; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.